Fermenta Biotech informs about outcome of board meeting

06 May 2021 Evaluate
Fermenta Biotech has informed that the board of directors of the company at its meeting held on May 6, 2021 has approved the following, appointment of Krishna Datla (DIN: 00003247) as a Whole-time Director of the Company (Key Managerial Personnel), designated as Executive Vice-Chairman, for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting; appointment Prashant Nagre (DIN: 09165447) as an additional director on the Board of Directors of the Company with effective from May 6, 2021; and appointment of Prashant Nagre as (DIN: 09165447) as the Managing Director of the Company (Key Managerial Personnel) for a period of 3 years commencing from May 9, 2021 to May 8, 2024, subject to members' approval at their ensuing general meeting. Requisite details of directors in terms of SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and affirmation pursuant to BSE Circular LIST/COMP/14/2018-19 dated June 20, 2018 are provided in Annexure 1. A copy of the Press Release for the same is attached.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

264.70 -4.30 (-1.60%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×